| 1 |
Microrna-9a Regulates Aging of Germ Line Stem Cells Through N-Cadherin
Yoni Epstein, Human Biology, University of Haifa, Haifa, Israel |
 |
|
| 2 |
MicroRNAs in the Stem Cell Niche - the Key for Cellular Longevity
Marina Volin, Human Biology, University of Haifa, Haifa, Israel |
|
|
| 3 |
In-House Preparation of DMEM from Powder: a Case Study in Cell Therapy Process Development
Yonatan Levinson, Pluristem Therapeutics, Haifa, Israel |
|
|
| 4 |
The Process Is The Product: A Novel Fully Automated, Controlled, Monitored and Scalable 2D Expansion System for Asc’s
Dotan Hoffman, Pluristem Therapeutics Ltd., Haifa, Israel |
|
|
| 5 |
Bringing Cell Therapy up to Patient Bed Side – the Development of an Automated and Controlled Point of Care Cell Thawing Device
Anna Zaretsky Rits, Development, Pluristem Therapeutics, Haifa, Israel |
|
|
| 6 |
Mechanism of Action of PLX-PAD Cells in Muscle Regeneration
Dana Fuchs-Telem, Pluristem Ltd., Haifa, Israel
|
|
|
| 7 |
The Radio-Mitigating Effect of PLX-R18, a Placenta -Derived Cellular Therapy, in Hematopoetic Acute Radiation Syndrome
Pinzur Lena, Pluristem Ltd. Haifa, Israel |
|
|
| 8 |
MiR-184 Promotes Keratinocyte Adhesion as Essential Part of the Differentiation Process and Barrier Formation
Friederike Leesch, Technion - Israel Institute of Technology, Haifa, Israel |
|
|
| 9 |
Regulation of Pax6 and Sox2 in Eye Morphogenesis and Corneal Homeostasis by MIR450
Swarnabh Bhattacharya, Technion - Israel Institute of Technology, Haifa, Israel |
|
|
| 10 |
MiR-184 Represses Keratinocyte Proliferation And Induces Stem Cell Differentiation
Sara Nagossa, Technion - Israel Institute of Technology, Haifa, Israel |
|
|
| 11 |
Ras as a Switch between “Naïve” and “Primed” States of Pluripotency
Anna Altshuler, Technion - Israel Institute of Technology, Haifa, Israel |
|
|
| 12 |
Extracellular Matrix-Based Gels as Cell Platform for Cardiac Regeneration
Yael Efraim, Technion - Israel Institute of Technology, Haifa, Israel |
|
|
| 13 |
Liquefied Pancreatic ECM: a Novel Encapsulation Platform for Diabetes Therapy
Stasia Krishtul,Technion - Israel Institute of Technology, Haifa, Israel |
|
|
| 14 |
Nano-Ghosts for Selective Drug Delivery to and Across the Blood Brain Barrier
Noa Cohen Anavy, Technion - Israel Institute of Technology, Haifa, Israel |
|
|
| 15 |
Tropoelastin coated porous scaffolds enhance vascular network formation of adipose derived endothelial and mesenchymal stem cells
Shira Landau, Technion - Israel Institute of Technology, Haifa, Israel |
|
|
| 16 |
Forces and regulation of vascular network
Shira Landau, Technion - Israel Institute of Technology, Haifa, Israel |
|
|
| 17 |
Flow bioreactor for on-line imaging of vasculogenic dynamic in 3D engineered tissue
Barak Zohar, Technion - Israel Institute of Technology, Haifa, Israel |
|
|
| 18 |
Disease modeling and potential therapies for skin/corneal pathology: A lesson from pluripotent stem cells and mouse models.
Waseem Nasser, Technion - Israel Institute of Technology, Haifa, Israel |
|
|
| 19 |
Human Endothelial Cells Isolated from an Adult Vein Form Vessel Networks within Engineered Muscle Grafts
Luba Perry, Technion - Israel Institute of Technology, Haifa, Israel |
|
|
| 20 |
Adipogenesis of 3T3L1 Cells Subjected to Tensile Deformation under Various Glucose Concentrations
Maayan Lustig, Tel Aviv University, Tel Aviv, Israel |
|
|
| 21 |
The Epigenetic Characterization of Liver to Endocrine Pancreas Transdifferentiation
Adi Har-Zahav, Tel Aviv University, Tel Aviv, Israel |
|
|
| 22 |
The Common Transcriptome Signature of Human and Murine Oral Mucosa-Derived Stem Cells
Ina Arie, Tel Aviv University, Tel Aviv, Israel |
|
|
| 23 |
A Platform to Identify, Isolate and Target Cancer Stem Cells Using Late-Passage Patient-Derived Xenograft Model: Malignant Rhabdoid Tumor as an Example
Revital Caspi, Tel Aviv University, Tel Aviv, Israel |
|
|
| 24 |
DAP5-Dependent Translation is Required for Human Embryonic Stem Cell Differentiation
Yael Yoffe, Weizmann Institute of Science, Rehovot, Israel |
|
|
| 25 |
The Role of miRNAs in Adult Cells Reprogramming along the Endocrine Pancreatic Lineage
Alex Osnis, TAU/Sheba Medical Center, Hod Ha Sharon, Israel |
|
|
| 26 |
Reprogramming of Human Somatic Cells into Pluripotent Stem Cells (iPSC) and Gene-Editing to Build Disease Specific in Vitro Models
Bjørn Holst, Bioneer A/S, Hoersholm, Denmark |
 |
|
| 27 |
Embryonic Stem Cells in Science and Agriculture
Sharon Schlesinger, Hebrew University, Rechovot, Israel |
|
|
| 28 |
Mesenchymal stem cells and their derived exosomes exert therapeutic effects in Duchenne muscular dystrophy in mouse and in vitro models
Ariel Bier, Bar-Ilan , Ramat-Gan University, Israel |
|
|
| 29 |
Heart Failure Environment Switches Resident and Transplanted Mesenchymal Stromal Cells Toward a Pro-Inflammatory Phenotype and Impairs Their Reparative Properties via Toll Like Receptor-4
Nili Naftali-Shani, Tel-Hashomer, Israel |
|
|
| 30 |
Spontaneous Single-Copy Loss of TP53 in Human Embryonic Stem Cells Markedly Increases Cell Proliferation and Survival
Hadar Amir, Tel Aviv Sourasky Medical center, Tel Aviv, Israel |
|
|
| 31 |
Isolated Subpopulation of Highly Potent Human Derived Expanded Placental Stromal Cells (hPSC) in Regenerative Medicine and for Mitigation Acute Lethal Radiation Syndrome
Evgenia Volinsky, The Hebrew University of Jerusalem, Jerusalem, Israel |
|
|
| 32 |
The NK killer receptor Ncr1 shapes tumor architecture to prevent metastasis
Ariella Glasner, The Hebrew University of Jerusalem, Jerusalem, Israel |
|
|
| 33 |
Reversion of FMR1 methylation and silencing by editing the triplet repeats in Fragile-X iPSC-derived neurons
Tomer Halevy, The Hebrew University of Jerusalem, Jerusalem, Israel |
|
|
| 34 |
Derivation and Differentiation of Haploid Human Embryonic Stem Cells
Ido Sagi, The Hebrew University of Jerusalem, Jerusalem, Israel |
|
|
| 35 |
Unbiased Screening For Chemotherapy Resistance Genes Using Haploid Human Embryonic Stem Cells
Mordecai Peretz, The Hebrew University of Jerusalem, Jerusalem, Israel |
|
|
| 36 |
VEGF is Both Essential and Sufficient for Increasing Overall Hematopoietic Output via Generating Stable Extra-Medullary Stem Cell Niches
Myriam Grunewald, Dev Biol & Cancer Res, Hebrew University, Jerusalem, Israel |
|
|
|
| 37 |
Engineering of Contractile Human Cardiac Tissue from Pluripotent Stem Cell-derived Cardiomyocytes in a Chemically-defined 3D Culture
Dana Hayoun-Neeman, Ben Gurion University of the Negev, Beer-Sheva, Israel |
|
|
| 38 |
Ex-Vivo Induced Regulatory Human/Murine Mesenchymal Stem Cells as Immune Modulators
Osnat Almogi-Hazan, Hadassah University Hospital, Jerusalem, Israel |
|
|
| 39 |
Human Bone Marrow Mesenchymal Stromal Cells Derived Exosomes as Immunomodulators – Molecular Mechanisms
Drirh Khare, Hadassah-Hebrew University Medical Center, Jerusalem, Israel |
|
|
| 40 |
Generation of Clinically Compatible and Genetically Stable iPS Cell Lines from Human Peripheral and Cord Blood Using Microrna-Facilitated Srrna Reprogramming
Brad Hamilton, Stemgent, USA |
 |
